Ann Lab Med.  2019 Jul;39(4):414-416. 10.3343/alm.2019.39.4.414.

First Case in Korea of Group B Streptococcus With Reduced Penicillin Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Protein 2X

• Yi A
• Kim CK
• Kimura K
• Arakawa Y
• Hur M
• Yun YM
• Moon HW

• KMID: 2438892
• DOI: http://doi.org/10.3343/alm.2019.39.4.414

Abstract

No abstract available.

MeSH Terms

Amino Acid Substitution*
Korea*
Penicillin-Binding Proteins*
Penicillins*
Streptococcus*
Penicillin-Binding Proteins
Penicillins

Reference

1. Lamagni TL, Keshishian C, Efstratiou A, Guy R, Henderson KL, Broughton K, et al. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991–2010. Clin Infect Dis. 2013; 57:682–688. PMID: 23845950.

2. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008; 299:2056–2065. PMID: 18460666.

3. Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59:1–36.

4. Dahesh S, Hensler ME, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother. 2008; 52:2915–2918. PMID: 18541727.

5. Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother. 2008; 52:2890–2897. PMID: 18490507.

6. Sigauque B, Kobayashi M, Vubil D, Nhacolo A, Chauque A, Moaine B, et al. Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001–2015. PLoS One. 2018; 13:e0191193. PMID: 29351318.

7. CLSI. Performance standards for antimicrobial susceptibility testing. 27th Information Supplement, M100-S28. Wayne, PA: Clinical and Laboratory Standards Institute;2017.

8. Schuurman T, de Boer RF, Kooistra-Smid AM, van Zwet AA. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol. 2004; 42:734–740. PMID: 14766845.

9. Kimura K, Nagano N, Arakawa Y. Classification of group B streptococci with reduced beta-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs. J Antimicrob Chemother. 2015; 70:1601–1603. PMID: 25667406.

10. Nagano N, Nagano Y, Kimura K, Tamai K, Yanagisawa H, Arakawa Y. Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother. 2008; 52:4258–4267. PMID: 18809936.